 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Journal: Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up. (Pubmed Central) - Jul 11, 2019
...The stem cell-based medicinal product (a composite of culture-expanded allogeneic hUCB-MSCs and hyaluronic acid hydrogel [Cartistem]) was applied to the lesion site...The application of this novel stem cell-based medicinal product appears to be safe and effective for the regeneration of durable articular cartilage in osteoarthritic knees. Stem Cells Translational Medicine 2017;6:613-621.
- | NN1213 / Novo Nordisk, Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion, Trial completion date: Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell (clinicaltrials.gov) - Apr 10, 2019
P=N/A, N=30, Completed, Sponsor: Samsung Medical Center
Stem Cells Translational Medicine 2017;6:613-621. Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018
- | Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion: Evaluation of Safety and Exploratory Efficacy of CARTISTEM (clinicaltrials.gov) - Dec 22, 2017
P1/2, N=12, Completed, Sponsor: Medipost Co Ltd.
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed
- Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial primary completion date: Evaluation of Safety and Exploratory Efficacy of CARTISTEM (clinicaltrials.gov) - Apr 20, 2017
P1/2, N=12, Active, not recruiting, Sponsor: Medipost Co Ltd.
Active, not recruiting --> Completed Trial primary completion date: May 2016 --> Jun 2017
- Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
New trial: Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell (clinicaltrials.gov) - Apr 28, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: Samsung Medical Center
- ||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion: Follow-Up Study of CARTISTEM (clinicaltrials.gov) - Jan 7, 2016
P3, N=103, Completed, Sponsor: Medipost Co Ltd.
Trial primary completion date: May 2016 --> Jun 2017 Active, not recruiting --> Completed
- | Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Enrollment closed: Evaluation of Safety and Exploratory Efficacy of CARTISTEM (clinicaltrials.gov) - Jun 2, 2015
P1/2, N=12, Active, not recruiting, Sponsor: Medipost Co Ltd.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial primary completion date: Evaluation of Safety and Exploratory Efficacy of CARTISTEM (clinicaltrials.gov) - Apr 14, 2015
P1/2, N=12, Recruiting, Sponsor: Medipost Co Ltd.
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2015 --> Jun 2016
- Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Clinical: Cartistem: Safety and Efficacy of Allogenic Umbilical Cord Blood-derived Mesenchymal Stem Cell Product (clinicaltrials.gov) - Jan 15, 2015
P0, N=28, Enrolling by invitation, Sponsor: Samsung Medical Center
- ||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Enrollment closed: Follow-Up Study of CARTISTEM (clinicaltrials.gov) - Sep 19, 2014
P3, N=103, Active, not recruiting, Sponsor: Medipost Co Ltd.
Trial primary completion date: Jan 2015 --> Jun 2016 Recruiting --> Active, not recruiting
- |||||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
New P3 trial: A Follow-up Study of CARTISTEM (clinicaltrials.gov) - Aug 13, 2013
P3, N=102, Recruiting, Sponsor: Dong-A Pharmaceutical Co., Ltd.
- |||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Enrollment open: A Follow-up Study of CARTISTEM (clinicaltrials.gov) - Aug 12, 2013
P3, N=102, Recruiting, Sponsor: Dong-A Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
New P1/2 trial: Evaluation of Safety and Exploratory Efficacy of CARTISTEM (clinicaltrials.gov) - Nov 22, 2012
P1/2, N=12, Recruiting, Sponsor: Medipost Co Ltd.
- |||||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
New P3 trial: Follow-Up Study of CARTISTEM (clinicaltrials.gov) - Jun 21, 2012
P3, N=103, Recruiting, Sponsor: Medipost Co Ltd.
- ||||||| Cartistem (mesenchymal stem cell therapy for cartilage repair) / Medipost
Trial completion: Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury (clinicaltrials.gov) - Apr 18, 2012
P3, N=104, Completed, Sponsor: Medipost Co Ltd.
Not yet recruiting --> Recruiting Recruiting --> Completed